- Laboratory
- Laboratory medicine
- Rapid myocardial infarction test
- Hangzhou Biotest Biotech Co. Ltd.
Rapid cardiovascular disease test MCKMB-LC41for myocardial infarctioncreatine kinaseserum
Add to favorites
Compare this product
Characteristics
- Applications
- for cardiovascular diseases, for myocardial infarction
- Tested parameter
- creatine kinase
- Sample type
- serum, plasma, whole blood
- Analysis mode
- fluorescence immunoassay
- Result display time
3 min
Description
Overview
The Creatine Kinase MB (CK‑MB) Quantitative Rapid Test is a microfluidic fluorescent immunoassay designed for use with the Microfluidic Immunofluorescence Analyzer. In vitro diagnostic for quantitative measurement of CK‑MB in human venous whole blood, plasma (Lithium Heparin) and serum.
Platform
FluidicNow Microfluidic Platform; intended for use with the Microfluidic Immunofluorescence Analyzer.
Product Features
Product Specification (table)
Principle: Microfluidic immunoassay
Format: Biochip (microfluidic biochip)
Certificate: CE
Specimen: Whole blood (venous) / Serum / Plasma (Lithium Heparin)
Temperature (storage/operation): 2-30 ℃
Shelf life: 24 months
Ordering Information
Cat.No: MCKMB-LC41 — Product: Creatine Kinase MB (CK‑MB) Quantitative Rapid Test — Specimen: WB/S/P — Format: Biochip — Pack: 25 tests per pack
Technical characteristics
The Creatine Kinase MB (CK‑MB) Quantitative Rapid Test is a microfluidic fluorescent immunoassay designed for use with the Microfluidic Immunofluorescence Analyzer. In vitro diagnostic for quantitative measurement of CK‑MB in human venous whole blood, plasma (Lithium Heparin) and serum.
Platform
FluidicNow Microfluidic Platform; intended for use with the Microfluidic Immunofluorescence Analyzer.
Product Features
- Easy operation suitable for near‑patient testing
- Results in approximately 3 minutes
- Comprehensive assay menu on the analyzer
- Quantitative results comparable to CLIA methods
Product Specification (table)
Principle: Microfluidic immunoassay
Format: Biochip (microfluidic biochip)
Certificate: CE
Specimen: Whole blood (venous) / Serum / Plasma (Lithium Heparin)
Temperature (storage/operation): 2-30 ℃
Shelf life: 24 months
Ordering Information
Cat.No: MCKMB-LC41 — Product: Creatine Kinase MB (CK‑MB) Quantitative Rapid Test — Specimen: WB/S/P — Format: Biochip — Pack: 25 tests per pack
Technical characteristics
- Assay principle: Microfluidic immunoassay with fluorescent detection
- Test format: Microfluidic biochip
- Compatible specimens: Venous whole blood, serum, plasma (Lithium Heparin)
- Intended use: Quantitative determination of CK‑MB (cardiac biomarker)
- Analyzer: For use with Microfluidic Immunofluorescence Analyzer on FluidicNow platform
- Time to result: ~3 minutes
- Certificate: CE
- Storage/operating temperature range: 2-30 ℃
- Shelf life: 24 months
- Packaging: 25 tests/pack (Cat.No: MCKMB-LC41)
Catalogs
No catalogs are available for this product.
See all of Hangzhou Biotest Biotech Co. Ltd.‘s catalogsOther Hangzhou Biotest Biotech Co. Ltd. products
FluidicNow Microfluidic Platform
Related Searches
- Assay kit
- Rapid lateral flow test
- Blood rapid diagnostic test
- Immunoassay rapid diagnostic test
- Infectious disease assay kit
- Cassette rapid diagnostic test
- Serum rapid diagnostic test
- Virus rapid diagnostic test
- Plasma rapid diagnostic test
- Whole blood rapid diagnostic test
- Infectious disease rapid diagnostic test
- Urine rapid screening test
- Rapid respiratory infection test
- Test strip
- Bacteria rapid diagnostic test
- Strip rapid diagnostic test
- COVID-19 rapid diagnostic test
- Rapid feces test
- Rapid drug abuse test
- Feces test kit
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.